Related Experiment Video
Updated: May 9, 2026
09:33
Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Summary
New Alzheimer disease (AD) diagnostic tests enable individuals to plan for the future, including the option of rational suicide. This empowers high-risk individuals to make informed decisions about their lives and end-of-life planning.
Area of Science:
- Neuroscience
- Medical Ethics
- Public Health
Background:
- Emerging presymptomatic diagnostic tests for Alzheimer disease (AD) are becoming available.
- These tests include invasive procedures and cognitive assessments.
- Genetic testing for AD risk is also evolving.
Purpose of the Study:
- To analyze the implications of presymptomatic AD diagnostic tests on end-of-life planning.
- To discuss the ethical considerations surrounding the disclosure of AD risk information.
- To advocate for patient autonomy in the context of AD risk assessment.
Main Methods:
- Review of current literature on AD diagnostics and genetic testing.
- Ethical analysis of patient autonomy and informed consent.
- Discussion of the societal and psychological impact of presymptomatic testing.
Main Results:
- Presymptomatic AD tests offer individuals the ability to plan for potential future cognitive decline.
- This includes the option of rational suicide as a means of maintaining control.
- Current communication strategies and research protocols may disrespect patient autonomy.
Conclusions:
- The availability of presymptomatic AD diagnostics necessitates a reevaluation of how risk information is communicated.
- Respecting patient autonomy means acknowledging and supporting all options, including planned suicide.
- Ethical frameworks must adapt to the realities of early AD detection and individual choice.
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Psychosurgery
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...